Continental Breakfast

 

Welcoming remarks by Howard Kaufman, MD, 

Director of Rush University Cancer Center and Scott Seaman, Esq, and Charlene McMann,

Co-Founders, Chicago Blood Cancer Foundation

 

Introductory remarks by symposium chair, Stephanie A. Gregory, MD, FACP, 

The Elodia Kehm Chair of Hematology, Rush University Medical Center and Rush University

Cancer Center

 

Follicular Lymphoma Basics; and Advances in First Line Treatment and

Management of Asymptomatic and/or Low Tumor Burden Disease.

 

Brad S. Kahl, MD, Director of Lymphoma Service and Clinical Research Director for Hematologic Malignancies for the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center.

 

Management of Symptomatic, High Tumor Burden or Bulky Disease; and

What to do if Chemo isn’t Working (So That’s What Presentation Refractory Means).

 

Mathias J. Rummel, MD, PhD, Head of the Department of Hematology at the Clinic for Hematology and Medical Oncology at the Justus-Liebig University- Hospital, Gießen, Germany and Founder of StiL (pronounced 'steel'), the Study Group for Indolent Lymphomas.

 

Coffee Break

 

Is Watch & Wait Out of Date? What Early Treatments Should Be Considered?

Is Rituximab Maintenance for Everyone? 

 

A lively look at emerging paradigms and new approaches to treating Follicular Lymphoma. Rush expert, Parmeswaran Venugopal, MD, Samuel G.Taylor III MD Professor of Oncology; Associate Director, Division of Hematology-Oncology-Cell Therapy; Director, Section of Hematology at Rush University Medical Center joins guest faculty, Dr. Brad S. Kahl, Principle Investigator on the RESORT Trial, and Dr. Mathias J. Rummel, (bendamustine) and Dr. Stephen J. Schuster, Director, Lymphoma Program; Director, Lymphoma Translational Research, Abramson Cancer Center, the Perelman Center for Advanced Medicine, The University of Pennsylvania Health System.

 

Latest Options for Relapse; and What if Chemo isn’t Working(Refractory Disease)?

 

Christopher R Flowers, MD, MS, Director, Lymphoma Program; Winship Cancer Institute; Medical Director, Oncology Data Center; and Associate Professor, Hematology & Medical Oncology, Associate Professor, Bone Marrow and Stem Cell Transplantation, Emory University School of Medicine.

 

Progress in Stem Cell Transplantation: Curative for Some Patients,

Now How Might We Cure More?

 

Dr. Christopher R.  Flowers along with Rush’s transplant experts and researchers, Henry Fung, MD, FRCPE, Coleman Foundation Professor of Blood and Marrow Transplantation, Director, Bone Marrow Transplant and Cell Therapy and Sunita Nathan, MD, Assistant Professor of Medicine, Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center in an exploration of who benefits most from transplant and the many advances in autologous (patient’s own cells) and allogeneic (donor) transplantation.

 

Lunch Break with presentation

 

The Winding Road: Our Journeys to Long Term Survival.

 

Lunch while listening to 10-year refractory follicular lymphoma survivor Betsy de Parry, author, journalist, television host and cancer advocate, share tips and tales of optimal survival.

 

How Close Are We To Cure?  The Most Exciting and Novel Treatments in the Pipeline.

 

Dr. Stephen J. Schuster, Director, Lymphoma Program; Director, Lymphoma Translational Research, Abramson Cancer Center, the Perelman Center for Advanced Medicine, The University of Pennsylvania Health System.

 

The Road Ahead: Managing Follicular Lymphoma for Long Term Optimal Survivorship.

 

Guest faculty and Rush faculty, key opinion leaders in the lymphoma world, share their best thoughts on where we are headed and what survivors can do to help improve outcome and go the distance. Joining our panel of experts is Janine E. Gauthier, PhD, Director Clinical Services, Cancer Integrative Medicine Program; and Director of Psychosocial Services, Rush University Medical Center. 

 

The panel will touch on such topics as:

• the importance of obtaining a second opinion from a lymphoma expert

• the role of complementary and integrative medicine

• can stress make my cancer relapse?

• what is Myelodysplastic Syndrome and how is it treated?

• what is transformation and do we know enough to reduce its risks.

• is a clinical trial right for you; evauating them with your oncologist